Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 5 48-5, 2003, Pages

  Chiu, Hawjyh ^a   Gardner, Carol R ^a   Dambach, Donna M ^a,b   Brittingham, Jennie A ^a   Durham, Stephen K ^b   Laskin, Jeffrey D ^a   Laskin, Debra L ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Cytokines; Liver; Oxidative stress; Tissue injury; Transcription factors

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; CYTOKINE RECEPTOR; GLUTATHIONE; HEME OXYGENASE 1; PARACETAMOL; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY; WESTERN BLOTTING;

EID: 0142244128     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00219.2003     Document Type: Article

References (38)

1. Blazka ME, Bruccoleri A, Simeonova PP, Germolec DR, Pennypacker KR, and Luster MI. Acetaminophen-induced hepatotoxicity is associated with early changes in AP-1 DNA binding activity. Res Commun Mol Pathol Pharmacol 92: 259-273, 1996.
2. Blazka ME, Elwell MR, Holladay SD, Wilson RE, and Luster MI. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 24: 181-189, 1996.
3. Blazka ME, Germolec DR, Simeonova P, Bruccoleri A, Pennypacker KR, and Luster MI. Acetaminophen-induced hepatotoxicity is associated with early changes in NF-κB and NF-IL6 DNA binding activity. J Inflamm 47: 138-150, 1995.
4. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, and Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133: 43-52, 1995.
5. Boess F, Bopst M, Althaus R, Polsky S, Cohen SD, Eugster HP, and Boelsterli UA. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice. Hepatology 27: 1021-1029, 1998.
6. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, and Pohl LR. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298, 2002.
7. Chen G and Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635, 2002.
8. Chiu H, Brittingham JA, and Laskin DL. Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol Appl Pharmacol 181: 106-115, 2002.
9. Dambach DM, Watson LM, Gray KR, Durham SK, and Laskin DL. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35: 1093-1103, 2002.
10. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 36: 181-199, 2000.
11. Ferret PJ, Hammoud R, Tulliez M, Tran A, Trebeden H, Jaffray P, Malassagne B, Calmus Y, Weill B, and Batteux F. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 33: 1173-1180, 2001.
12. Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang XJ, DeGeorge GL, Laskin JD, and Laskin DL. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 27: 748-754, 1998.
13. Gardner CR, Laskin JD, Dambach DM, Chiu H, Durham SK, Zhou P, Bruno M, Gerecke DR, Gordon MK, and Laskin DL. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxiciol Appl Pharmacol. In press.
14. Guaiquil VH, Farber CM, Golde DW, and Vera JC. Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione. J Biol Chem 272: 9915-9921, 1997.
15. Hohmann HP, Remy R, Brockhaus M, and van Loon AP. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264: 14927-14934, 1989.
16. Karin M and Lin A. NF-kappaB at the crossroads of life and death. Nat Immun 3: 221-227, 2002.
17. Kyle ME, Miccadei S, Nakae D, and Farber JL. Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun 149: 889-896, 1987.
18. Laskin DL and Gardner CR. Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity. In: Drug-Induced Liver Diseases, edited by Kaplowitz N and DeLeve LD. New York: Marcel Dekker, 2003, p. 183-212.
19. Laskin DL, Gardner CR, Price VF, and Jollow DJ. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21: 1045-1050, 1995.
20. Lawrence T, Gilroy DW, Colville-Nash PR, and Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7: 1291-1297, 2001.
21. Levy MA, Tsai YH, Reaume A, and Bray TM. Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 281: L172-L182, 2001.
22. a. Luster MI, Simeonova P, Gallucci RM, Matheson JM, and Yucesoy B. Immunotoxicology: role of inflammation in chemical-induced hepatotoxicity. Int J Immunopharmacol 22: 1143-1147, 2000.
23. Maines MD. Heme Oxygenase: Clinical Applications and Functions. Boca Raton, FL: CRC, 1992.
24. Mates M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153: 83-104, 2000.
25. Mirochnitchenko O, Weisbrot-Lefkowitz M, Reuhl K, Chen L, Yang C, and Inouye M. Acetaminophen toxicity. Opposite effects of two forms of glutathione peroxidase. J Biol Chem 274: 10349-10355, 1999.
26. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, and Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 187: 185-194, 1973.
27. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, and Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187: 211-217, 1973.
28. Morales A, Garcia-Ruiz C, Miranda M, Mari M, Colell A, Ardite E, and Fernandez-Checa JC. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma-glutamylcysteine synthetase. J Biol Chem 272: 30371-30379, 1997.
29. Nakae D, Yamamoto K, Yoshiji H, Kinugasa T, Maruyama H, Farber JL, and Konishi Y. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol 136: 787-795, 1990.
30. Oguro T, Takahashi Y, Ashino T, Takaki A, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, and Yoshida T. Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver. FEBS Lett 516: 63-66, 2002.
31. Pahl HL and Baeuerle PA. Oxygen and the control of gene expression. Bioessays 16: 497-502, 1994.
32. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, and Mohler KM. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160: 943-952, 1998.
33. Rahman I and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16: 534-554, 2000.
34. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, and Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802, 1993.
35. Shaulian E and Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
36. Simpson KJ, Lukacs NW, McGregor AH, Harrison DJ, Strieter RM, and Kunkel SL. Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis. J Pathol 190: 489-494, 2000.
37. Yamada Y and Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 152: 1577-1589, 1998.
38. Zampetaki A, Minamino T, Mitsialis SA, and Kouremabanas S. Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp Biol Med (Maywood) 228: 442-446, 2003.